|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.49 GBX | -1.52% |
|
-3.85% | +8.62% |
| 2023 | FTSE 100 Finishes Slightly Lower After Steady Session | DJ |
| 2023 | Synairgen names Phytome's Joseph Colliver as CFO | AN |
(via NewsDirect)
The drug is being developed to help patients with respiratory viruses such as influenza virus, RSV, and SARS- CoV-2. The plan was formulated after a year of data collection and consultation with experts. He also highlights the company's relatively strong cash position, which he says will "allow [
+44 20 7989 0813
uk@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.
Copyright (c) 2023 TheNewswire - All rights reserved., source
| 1st Jan change | Capi. | |
|---|---|---|
| +8.62% | 16.28M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
SYNAIRGEN PLC 
